NCT07638150
PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)
Not Yet Recruiting
NAAges 18+InterventionalH. Lee Moffitt Cancer Center and Research InstituteInvestigator-initiated
~20 participants
Updated 2026-06-10 on ClinicalTrials.gov
What's tested:Mediterranean Diet
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of Enrollment
Measured over Up to 1 year
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Tiffany Carson, PhD, MPH · PRINCIPAL_INVESTIGATOR · Moffitt Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Newly diagnosed stage I-III breast cancer.
Treatment-naïve; no neoadjuvant therapy planned.
Surgery scheduled at Moffitt in 1-2 months.
Post-menopausal.
BMI 28-35 kg/m².
NCI Fruit \& Vegetable Screener \<5 servings/day.
Willing to consume only study-provided meals.
Exclusion
Stage IV/metastatic disease.
Prior cancer.
Surgery scheduled sooner than 4-5 weeks.
NCI FVS ≥5 servings/day.
Celiac disease, severe food allergies, severe renal disease, uncontrolled diabetes, or medically prescribed incompatible diets.
What this trial measures
- Feasibility of EnrollmentUp to 1 year
Percentage of eligible participants who enroll.
- Retention8 weeks post-surgery
Percentage of enrolled participants will complete assessments at both timepoints
- AdherenceAt 4 weeks.
Percentage of participants who consume ≥70% of study meals.
- Acceptability8 weeks post-surgery
Percentage of participants who rate overall satisfaction as "agree" and "strongly agree."